CRP and schizophrenia: We assessed the proportions of patients displaying a marker of inflammation (CRP) in two independent samples (in chronically ill patients with schizophrenia and over repeated admissions in patients experiencing an acute psychotic episode) and the ability of CRP to predict cortical thickness.